605369.SH
拱东医疗
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 16.97
−1.74%Year over year
Reported trailing growth
- Revenue
- +4.7%
- EBITDA
- —
- EBIT
- -55.2%
- EPS
- -62.1%
- Free cash flow
- +189.6%
- Operating cash flow
- +50.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.2%
- EBITDA
- -25.8%
- EBIT
- -44.0%
- Net income
- -45.9%
- EPS
- -57.1%
- Free cash flow
- +8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026